David A. Siegel Prime Medicine, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 43,200 shares of PRME stock, worth $122,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,200

Previous 119,900 63.97%

Holding current value

$122,688

Previous $464,000 72.84%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$2.64 - $4.46 $202,488 - $342,082	-76,700 Reduced 63.97%	43,200 $126,000
Q3 2024 Nov 14, 2024	SELL	$3.41 - $6.7 $193,006 - $379,220	-56,600 Reduced 32.07%	119,900 $464,000
Q2 2024 Aug 14, 2024	BUY	$4.3 - $8.03 $53,750 - $100,374	12,500 Added 7.62%	176,500 $907,000
Q1 2024 May 15, 2024	BUY	$6.35 - $9.39 $749,300 - $1.11 Million	118,000 Added 256.52%	164,000 $1.15 Million
Q4 2023 Feb 14, 2024	BUY	$5.59 - $9.55 $257,140 - $439,300	46,000 New	46,000 $407,000

Others Institutions Holding PRME

# of Institutions

135

Shares Held

63M

Call Options Held

50.1K

Put Options Held

30.9K

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $272M

More about PRME

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account